Photo of Ivy Xun

Ivy Xun is an international trade analyst in Crowell & Moring’s Washington, D.C. office. She provides practice support to the International Trade Group on import regulatory matters pending before the Office of the U.S. Trade Representative and U.S. Customs and Border Protection. She works closely with attorneys developing courses of action for clients impacted by investigations under Section 301 of the Trade Act of 1974 and Section 232 of the Trade Expansion Act of 1962. Ivy also supports unfair trade investigations, including antidumping and countervailing duty investigations, sunset reviews, and changed circumstance reviews before the Department of Commerce and the International Trade Commission.

On December 16, 2024, the U.S. Department of Commerce published the final rule for Regulations Enhancing the Administration of the Antidumping and Countervailing Duty Trade Remedy Laws. Commerce’s final rule revised certain AD/CVD provisions, including those related to filing requirements, the application of cash deposits, indicators used in surrogate country selection, the application of…

On December 10, 2024, the Office of the United States Trade Representative (USTR) initiated an investigation of Nicaragua’s acts, policies, and practices related to labor rights, human rights, and the rule of law. The investigation will be conducted under Section 301 of the Trade Act of 1974. This is the first investigation that USTR has…

On November 14, 2024, Rep. John Moolenaar (R-Mich.), chair of the House Select Committee on the Chinese Communist Party, introduced the Restoring Trade Fairness Act, seeking to suspend China’s Permanent Normal Trade Relations (“PNTR”) status.

Click here to continue reading the full version of this alert.

Senate Finance Chairman Ron Wyden (D-OR) recently introduced a bill that formalizes the legislation he released in August, the Fighting Illicit Goods, Helping Trustworthy Importers, and Netting Gains (FIGHTING) for America Act. The FIGHTING for America Act would remove de minimis treatment for goods impacted by the Generalized System of Preferences (GSP) program, as…

On September 26, 2024, Texas-based syringe importer Retractable Technologies, Inc. (“Retractable”) filed a complaint before the United States Court of International Trade contesting the Office of the United States Trade Representative’s (USTR) 100 percent tariff rate on imported needles and syringes from China. The tariff increase became effective on September 27, 2024.  In conjunction with…